Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINO BIOPHARM

8.140
+0.0800.99%
Volume:72.65M
Turnover:590.30M
Market Cap:152.71B
PE:38.97
High:8.190
Open:8.100
Low:8.020
Close:8.060
52wk High:9.120
52wk Low:2.634
Shares:18.76B
HK Float Shares:18.76B
Volume Ratio:0.70
T/O Rate:0.39%
Dividend:0.09
Dividend Rate:1.11%
EPS(LYR):0.209
ROE:15.40%
ROA:5.07%
PB:4.19
PE(LYR):38.97
PS:4.58

Loading ...

Sino Biopharmaceutical - China's Nmpa Accepts Clinical Trial Application for Tqb3142 "Bcl-Xl Protac"

THOMSON REUTERS
·
Aug 12

Sino Biopharmaceutical's Investigational New Drug Application for Tumor Medicine Accepted by Chinese Regulators

MT Newswires Live
·
Aug 12

BRIEF-Sino Biopharmaceutical Says Application For Clinical Trial Of TQB3122 Accepted By NMPA

Reuters
·
Aug 11

Sino Biopharmaceutical - Application for Clinical Trial of Tqb3122 "Parp1 Inhibitor" Accepted by Nmpa

THOMSON REUTERS
·
Aug 11

Sino Biopharmaceutical Stock Rises 1.0% in Hong Kong

Dow Jones
·
Aug 11

Sino Biopharmaceutical Receives Chinese Regulatory Nod for Mid-stage Study of Tumor Drug

MT Newswires Live
·
Aug 08

BRIEF-Sino Biopharmaceutical Says Application For Phase II Clinical Trial On LM-24C5 "CEACAM5/4-1BB Bispecific Antibody" Approved By China NMPA

Reuters
·
Aug 07

Sino Biopharmaceutical - Application for Phase Ii Clinical Trial on Lm-24C5 "Ceacam5/4-1Bb Bispecific Antibody" Approved by China Nmpa

THOMSON REUTERS
·
Aug 07

Sino Biopharmaceutical Stock Falls 2.8% in Hong Kong

Dow Jones
·
Aug 07

Sino Biopharm Wins Breakthrough Therapy Status for Graft-Versus-Host Disease Drug in China

MT Newswires Live
·
Aug 06

BRIEF-Sino Biopharmaceutical's Rovadicitinib Tablet Included In Breakthrough Therapeutic Designation

Reuters
·
Aug 06

Sino Biopharmaceutical Ltd - Rovadicitinib Tablet Included in Breakthrough Therapeutic Designation

THOMSON REUTERS
·
Aug 06

BRIEF-Sino Biopharmaceutical Says NMPA Approves Clinical Trial For Sino Biopharm's TQC3302

Reuters
·
Aug 05

Sino Biopharm Gets China Nod for Soft Mist Inhalation Formulation Trial

MT Newswires Live
·
Aug 05

Sino Biopharmaceutical - Nmpa Approves Clinical Trial for Sino Biopharm's Tqc3302

THOMSON REUTERS
·
Aug 05

Sino Biopharmaceutical Stock Falls 1.0% in Hong Kong

Dow Jones
·
Aug 04

Sino Biopharmaceutical Stock Slips 2.7% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 01

LaNova Medicines Secures $300M Milestone Payment in Merck Collaboration

Reuters
·
Jul 30

Inventiva SA Reports €4.5 Million in H1 2025 Revenues, Up from Zero in H1 2024; Net Cash Used in Operating Activities Increases to (€53.9) Million

Reuters
·
Jul 30

Sino Biopharmaceutical Stock Rises 7.1% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 28